T. Rowe Price Associates’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $64M | Buy |
612,743
+580,766
| +1,816% | +$60.6M | 0.01% | 667 |
|
|
2025
Q1 | $3.73M | Buy |
31,977
+749
| +2% | +$87.4K | ﹤0.01% | 1347 |
|
|
2024
Q4 | $2.64M | Buy |
31,228
+3,366
| +12% | +$285K | ﹤0.01% | 1512 |
|
|
2024
Q3 | $2.5M | Buy |
27,862
+687
| +3% | +$61.7K | ﹤0.01% | 1540 |
|
|
2024
Q2 | $2.19M | Buy |
27,175
+1,901
| +8% | +$153K | ﹤0.01% | 1514 |
|
|
2024
Q1 | $2.02M | Sell |
25,274
-121,283
| -83% | -$9.68M | ﹤0.01% | 1556 |
|
|
2023
Q4 | $11.7M | Buy |
146,557
+123,949
| +548% | +$9.87M | ﹤0.01% | 1063 |
|
|
2023
Q3 | $1.58M | Buy |
22,608
+2,132
| +10% | +$149K | ﹤0.01% | 1566 |
|
|
2023
Q2 | $1.47M | Buy |
20,476
+4,227
| +26% | +$304K | ﹤0.01% | 1604 |
|
|
2023
Q1 | $1M | Buy |
16,249
+1,770
| +12% | +$109K | ﹤0.01% | 1784 |
|
|
2022
Q4 | $1.12M | Buy |
14,479
+380
| +3% | +$29.3K | ﹤0.01% | 1716 |
|
|
2022
Q3 | $630K | Sell |
14,099
-528
| -4% | -$23.6K | ﹤0.01% | 2002 |
|
|
2022
Q2 | $560K | Buy |
14,627
+245
| +2% | +$9.38K | ﹤0.01% | 2170 |
|
|
2022
Q1 | $595K | Buy |
14,382
+4,068
| +39% | +$168K | ﹤0.01% | 2256 |
|
|
2021
Q4 | $390K | Sell |
10,314
-9,796
| -49% | -$370K | ﹤0.01% | 2497 |
|
|
2021
Q3 | $663K | Sell |
20,110
-728,137
| -97% | -$24M | ﹤0.01% | 2233 |
|
|
2021
Q2 | $50.5M | Buy |
748,247
+120,909
| +19% | +$8.16M | ﹤0.01% | 1025 |
|
|
2021
Q1 | $35.5M | Sell |
627,338
-411,917
| -40% | -$23.3M | ﹤0.01% | 1124 |
|
|
2020
Q4 | $84.7M | Sell |
1,039,255
-9,730
| -0.9% | -$793K | 0.01% | 786 |
|
|
2020
Q3 | $74.7M | Sell |
1,048,985
-35,886
| -3% | -$2.56M | 0.01% | 742 |
|
|
2020
Q2 | $89.3M | Buy |
1,084,871
+339,511
| +46% | +$27.9M | 0.01% | 665 |
|
|
2020
Q1 | $43.9M | Sell |
745,360
-861,631
| -54% | -$50.7M | 0.01% | 826 |
|
|
2019
Q4 | $166M | Buy |
1,606,991
+898,120
| +127% | +$92.8M | 0.02% | 518 |
|
|
2019
Q3 | $14.3M | Buy |
708,871
+130,012
| +22% | +$2.63M | ﹤0.01% | 1233 |
|
|
2019
Q2 | $14.9M | Buy |
+578,859
| New | +$14.9M | ﹤0.01% | 1255 |
|